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ally added by Golgi-resident fucosyltransferases. Whereas fucosylated glycoconjugates are rare
in kinetoplastids, the biosynthesis of the nucleotide sugar GDP-Fuc has been shown to be essential in Trypanosoma brucei. Here we show that the single identifiable T. brucei fucosyltransferase
(TbFUT1) is a GDP-Fuc: β-D-galactose α-1,2-fucosyltransferase with an apparent preference for a
Galβ1,3GlcNAcβ1-O-R acceptor motif. Conditional null mutants of TbFUT1 demonstrated that
it is essential for both the mammalian-infective bloodstream form and the insect vector-dwelling
procyclic form. Unexpectedly, TbFUT1 was localized in the mitochondrion of T. brucei and found to
be required for mitochondrial function in bloodstream form trypanosomes. Finally, the TbFUT1 gene
was able to complement a Leishmania major mutant lacking the homologous fucosyltransferase
gene (Guo et al., 2021). Together these results suggest that kinetoplastids possess an unusual,
conserved and essential mitochondrial fucosyltransferase activity that may have therapeutic potential across trypanosomatids.

Introduction
The protozoan parasites of the Trypanosoma brucei group are the causative agents of human and
animal African trypanosomiasis. Bloodstream form T. brucei is ingested by the tsetse fly vector and
differentiates into procyclic form parasites to colonize the tsetse midgut. To then infect a new mammalian host, T. brucei undergoes a series of differentiations that allows it to colonize the fly salivary gland
and to be transferred to a new host during a subsequent blood meal (Matthews, 2005).
The surface coat of the bloodstream form is characterized by the GPI-anchored, N-glycosylated
and occasionally O-glycosylated variant surface glycoprotein (VSG) (Cross, 1996; Mehlert et al.,
1998; Pays and Nolan, 1998; Pinger et al., 2018; Schwede and Carrington, 2010), while procyclic cells express a family of GPI-anchored proteins called procyclins (Richardson et al., 1988;
Roditi et al., 1998; Treumann et al., 1997; Vassella et al., 2001), free glycoinositolphospholipids (Nagamune et al., 2004; Roper et al., 2005; Vassella et al., 2003), and a high molecular
weight glycoconjugate complex (Güther et al., 2009). The importance of glycoproteins to parasite
survival and infectivity has led to the investigation of enzymes for GPI anchor biosynthesis (Chang
et al., 2002; Nagamune et al., 2000; Smith et al., 2004; Urbaniak et al., 2014; Urbaniak et al.,
2008) and nucleotide sugar biosynthesis (Bandini et al., 2012; Denton et al., 2010; Kuettel et al.,
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2012; Sampaio Guther et al., 2021; Marino et al., 2010; Marino et al., 2011; Roper et al., 2002;
Roper et al., 2005; Stokes et al., 2008; Shaw et al., 2003; Turnock et al., 2007; Urbaniak et al.,
2006a; Urbaniak et al., 2006b; Urbaniak et al., 2013; Zmuda et al., 2019) as potential therapeutic targets.
Nucleotide sugars are used as glycosyl donors in many glycosylation reactions. GDP-fucose (GDP-
Fuc) was identified in the nucleotide sugar pools of T. brucei, Trypanosoma cruzi, and Leishmania
major (Turnock and Ferguson, 2007), and its biosynthesis is essential for parasite growth in procyclic
and bloodstream form T. brucei (Turnock et al., 2007) and in L. major promastigotes (Guo et al.,
2017). Interestingly, T. brucei and L. major use different pathways to synthesize GDP-Fuc. T. brucei
utilizes the de novo pathway in which GDP-Fuc is synthesized from GDP-mannose via GDP-mannose4,6-dehydratase (GMD) and GDP-4-keto-6-deoxy-D-mannose epimerase/reductase (GMER) (Sampaio
Guther et al., 2021; Turnock et al., 2007; Turnock et al., 2007). Conversely, L. major has two related
bifunctional D-
arabinose/L-
fucose kinase/pyrophosphorylase, AFKP80 and FKP40, that synthesize
GDP-Fuc from free fucose (Guo et al., 2017). Despite the aforementioned essentialities for GDP-Fuc
in T. brucei and L. major, the only structurally defined fucose-containing oligosaccharide in trypanosomatids is the low-abundance Ser/Thr-phosphodiester-linked glycan on T. cruzi gp72, a glycoprotein
that has been implicated in flagellar attachment (Allen et al., 2013; Cooper et al., 1993; Ferguson
et al., 1983; Haynes et al., 1996).
Fucosyltransferases (FUTs) catalyse the transfer of fucose from GDP-Fuc to glycan and protein
acceptors and are classified into two superfamilies (Coutinho et al., 2003; Lombard et al., 2014).
One superfamily contains all α1,3/α1,4-FUTs (carbohydrate active enzyme, CAZy, family GT10) and the
other contains all α1,2-, α1,6-, and protein O-fucosyltransferases (GT11, GT23, GT37, GT56, GT65,
GT68, and GT74; Martinez-Duncker, 2003). In eukaryotes, FUTs are generally either type II transmembrane Golgi proteins or ER-resident enzymes (POFUT1 and POFUT2) (Breton et al., 1998), but
two exceptions have been described: (i) PgtA, a cytoplasmic bifunctional β1,3-galactosyltransferase
α1,2-FUT found in Dictyostelium discoideum and Toxoplasma gondii (Rahman et al., 2016; Van Der
Wel et al., 2002) that is part of an oxygen-sensitive glycosylation pathway that attaches a pentasaccharide to the Skp1-containing ubiquitin ligase complex (West et al., 2010); and (ii) SPINDLY, a
protein O-fucosyltransferase that modifies nuclear proteins in Arabidopsis thaliana and T. gondii (Gas-
Pascual et al., 2019; Zentella et al., 2017).
T. brucei and other kinetoplastids contain a single mitochondrion. In the bloodstream form of
the parasite, this organelle has a tubular structure, while in the procyclic form it is organized in
a complex network with numerous cristae, reflecting the absence and presence, respectively, of
oxidative phosphorylation (Matthews, 2005; Priest and Hajduk, 1994). The parasite mitochondrion is further characterized by a disc-shaped DNA network called the kinetoplast (Jensen and
Englund, 2012) that is physically linked with the flagellum basal body (Ogbadoyi et al., 2003;
Povelones, 2014).
While secretory pathway and nuclear/cytosolic glycosylation systems have been studied extensively, little is known about glycosylation within mitochondria. A glycoproteomic approach in yeast
revealed several mitochondrial glycoproteins (Kung et al., 2009), but it was not determined whether
these were imported from the secretory pathway or glycosylated within the mitochondria by as yet
unknown glycosyltransferases. The only characterized example of a mitochondrial glycosyltransferase
is the mitochondrial isoform of mammalian O-GlcNAc transferase (OGT). O-GlcNAcylation is a cycling
modification, involved in signalling, in which OGT adds GlcNAc to Ser/Thr residues and O-GlcNAcase
(OGA) removes it (Bond and Hanover, 2015). Studies have shown that both mitochondrial OGT
(mOGT) and OGA are present and active in mammalian mitochondria and putative mitochondrial
targets have been identified (Banerjee et al., 2015; Sacoman et al., 2017). Further, a mammalian
mitochondrial UDP-GlcNAc transporter associated with mitochondrial O-GlcNAcylation has been
described (Banerjee et al., 2015). However, orthologues of OGT and OGA genes are not present in
kinetoplastids.
Here, we report on a gene (TbFUT1) encoding a mitochondrial α-1,2-fucosyltransferase protein
(TbFUT1) in T. brucei that is essential to parasite survival. Similar results were obtained in the related
trypanosomatid parasite L. major (Guo et al., 2021), extending this unexpected finding across the
trypanosomatid protozoans.
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Results
Identification, cloning, and sequence analysis of TbFUT1
The CAZy database lists eight distinct FUT families (see Introduction) (Lombard et al., 2014). One or
more sequences from each family were selected for BLASTp searches of the predicted proteins from
the T. brucei, T. cruzi, and L. major genomes (Supplementary file 1). Strikingly, only one putative
fucosyltransferase gene (TbFUT1) was identified in the T. brucei genome (GeneDB ID: Tb927.9.3600)
belonging to the GT11 family, which is comprised almost exclusively of α-1,2-FUTs (Coutinho et al.,
2003; Zhang et al., 2010). Homologues of TbFUT1 were also found in the T. cruzi and L. major
genomes and, unlike T. brucei, T. cruzi, and L. major, also encode for GT10 FUT genes (Supplementary file 1). Finally, Leishmania spp. express a family of α-1,2-arabinopyranosyltransferases (SCA1/2/L,
CAZy family GT79) that decorate phosphoglycan side chains and have been suggested to act as FUTs
in presence of excess fucose (Guo et al., 2021).
The TbFUT1 predicted amino acid sequence shows relatively low sequence identity to previously
characterized GT11 FUTs, for example, Helicobacter pylori (26%) or human FUT2 (21%) (Kelly et al.,
1995; Wang et al., 1999). Nevertheless, conserved motifs characteristic of this family can be identified (Figure 1A; Li et al., 2008; Martinez-Duncker, 2003). Motif I (aa 153–159) is shared with α-1,6-
FUTs and has been implicated in the binding of GDP-Fuc (Takahashi et al., 2000), whereas no clear
functions have yet been assigned to motifs II, III, and IV (aa 197–207, 265–273, and 13–18, respectively). Notably, TbFUT1 lacks an identifiable N-terminal signal peptide and has only a low-confidence
prediction for a type II membrane protein N-terminal transmembrane domain (0.34108 on TMHMM2.0 for residues 6–28). These two features would be expected of a typical Golgi-localized FUT (Breton
et al., 1998; Figure 1A). Indeed, further analysis of the TbFUT1 predicted amino acid sequence using
PSort II (43.5 % mitochondrion, 4.3 % secretory pathway, 26.1 % cytosolic, Horton and Nakai, 1997),
Target P (0.428 mitochondrial, 0.064 secretory, 0.508 other, Emanuelsson et al., 2000), and Mitoprot
(0.5774 probability of mitochondrial localization, Claros and Vincens, 1996) rated the localization as
most likely mitochondrial and identified a putative mitochondrial targeting motif (M/L … RR) with RR
at sequence positions 30 and 31. Conservation of this eukaryotic targeting motif has been previously
shown for other parasite mitochondrial proteins (Krnáčová et al., 2012; Long et al., 2008).
Additional BLASTp searches showed that there is generally a single TbFUT1 gene homologue in
each kinetoplastid species, and a phylogram of FUT sequences indicates that TbFUT1 homologues
form a distinct clade closest to bacterial α-1,2-FUT (Figure 1B).

Recombinant expression of TbFUT1
The TbFUT1 ORF was amplified from T. brucei 427 genomic DNA and cloned in the pGEX6P1 expression vector. The resulting construct (pGEX6P1-GST-PP-TbFUT1) encoded for the TbFUT1 ORF with
a glutathione-S-transferase (GST) tag at its N-terminus and a PreScission Protease (PP) cleavage site
between the two protein-encoding sequences. Sequencing confirmed what was subsequently deposited at TriTrypDB (Tb427_090021700) and identified two amino acid differences between TbFUT1 in
the 927 and 427 strains (L185V and T232A).
The pGEX6P1-GST-PP-TbFUT1 construct was expressed in Escherichia coli and the fusion protein
purified as described in Materials and methods. The identities of the two higher molecular weight
bands (Figure 2—figure supplement 1, lane 8) were determined by peptide mass fingerprinting. The
most abundant band was identified as TbFUT1, while the fainter band was identified as a subunit of
the E. coli GroEL chaperonin complex. The apparent molecular weight of GST-PP-TbFUT1 chimeric
protein (57 kDa) was consistent with the predicted theoretical molecular weight (58.1 kDa).

Recombinant TbFUT1 is active in vitro
The activity of recombinantly expressed GST-TbFUT1 fusion protein was tested by incubation with
GDP-[3H]Fuc, as a donor, and a panel of commercially available mono- to octasaccharides (Table 1)
selected from the literature as possible α-1,2-FUT substrates (Li et al., 2008; Wang et al., 1999;
Zhang et al., 2010). The effectiveness of each acceptor was evaluated based on the presence/absence
and intensities of the TLC bands corresponding to the radiolabelled reaction products (Figure 2 and
Table 1). GST-TbFUT1 showed best activity with Galβ1,3GlcNAc (LNB) (Figure 2, lane 2) and its β-O-
methyl glycoside (Figure 2, lane 21). Other larger oligosaccharides containing Galβ1,3GlcNAcβ1-
O-R as a terminal motif (LNT and LNH) were also good acceptors (Figure 2, lanes 11 and 15), with the
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Figure 1. Amino acid sequence and phylogenetic analyses of TbFUT1. (A) Sequence alignment of TbFUT1 and
other GT11 family fucosyltransferases (FUTs) shows that TbFUT1 (Tb927.9.3600) lacks a conventional N-terminal
type 2 membrane protein transmembrane domain (TM, grey box) but contains conserved motifs I–IV (black boxes).
A putative TbFUT1 TM (dashed box) overlaps with motif IV but does not align with the eukaryotic FUT TM and is
Figure 1 continued on next page
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most likely part of a cleavable N-terminal mitochondrial targeting sequence (residues 1–31 with cleavage at R30–
R31). Sequences used in the alignment: T. cruzi (TcCLB.506893.90), L. major (LmjF01.0100), H. pylori (AAC99764),
Homo sapiens FUT2 (AAC24453), and Mus musculus FUT2 (AAF45146). (B) A selection of known and predicted
fucosyltransferase protein sequences was aligned using ClustalΩ (Sievers et al., 2011), and the unrooted
phylogram shown was generated by iTOL (itol.embl.de) (Letunic and Bork, 2016). Single homologues of the
GT11 TbFUT1 were found in all the kinetoplastids (marked in green) and, collectively, these sequences form a
clade distant from other fucosyltransferase sequences, including the other kinetoplastid GT10 fucosyltransferases
(marked by a dashed line). No TbFUT1 homologues were found in apicomplexan parasites or in Euglena.

exception of iLNO (Figure 2, lane 13). Lactose was also recognized (Figure 2, lane 1), while LacNAc
and the LacNAc-terminating branched hexasaccharide LNnH were weak acceptors (Figure 2, lanes 3
and 10). Interestingly, TbFUT1 was also able to transfer fucose to 3′-fucosyllactose, albeit inefficiently
(Figure 2, lane 16), whereas no transfer could be seen to Galβ1,6GlcNAc (Figure 2, lane 17) or to
free Gal or β-Gal-O-methyl (Figure 2, lanes 9 and 20). As expected, no products were observed
when acceptor oligosaccharides were omitted from the reaction (Figure 2, lane 4). To confirm the
detected activities were specific to the recombinant GST-TbFUT1, and not due to some co-purifying
endogenous E. coli contaminant, the assay was also performed using material prepared from E. coli
expressing the empty pGEX6P1 vector. No transfer of radiolabelled fucose could be observed under
these conditions (Figure 2, lanes 5–7).
A band with the same mobility as free fucose was observed in all assay reactions and was considerably stronger in the presence of the GST-TbFUT1 preparation (Figure 2, lanes 1–4 and 9–22) than
Table 1. Acceptor substrates and semi-quantitative fucosyltransferase activities.
TbFUT1
activity

Lane of
Figure 1

Abbreviations* Name

Structure

+++

2, 6

LNB

Lacto-N-biose

Galβ1,3GlcNAc

+++

21

LNB-OMe

Lacto-N-biose-O-methyl

Galβ1,3GlcNAcβ-OMe

++

11

LNT

Lacto-N-tetraose

Galβ1,3GlcNAcβ1,3Galβ1,4Glc

++

14

LNH

Lacto-N-hexaose

Galβ1,3GlcNAcβ1,3(Galβ1,
4GlacNAcβ1,6)Galβ1,4Glc

++

1,5

Lac

Lactose

Galβ1,4Glc

+

13

iLNO

Iso-lacto-N-octaose

Galβ1,3GlcNAcβ1,3(Galβ1,
3GlcNAcβ1,3Galβ1,4GlcNAcβ1,6)
Galβ1,4Glc

+

3,7

LacNAc

N-acetyllactosamine

Galβ1,4GlcNAcN

+

10

LNnH

Lacto-N-neohexaose

Galβ1,4GlcNAcβ1,3
(Galβ1,4GlcNAcβ1,6)Galβ1,4Glc

+

12

LNnT

Lacto-N-neotetraose

Galβ1,4GlcNAcβ1,3Galβ1,4Glc

+

16

3′-FL

3′-Fucosyllactose

Galβ1,4(Fucα1,3)Glc

–

9

β-Gal

β-Galactose

β-Gal

–

15

GNG

β1,6-Galactosyl-N-acetyl
-glucosamine
Galβ1,6GlcNAc

–

17

1,6 GB

β1,6-Galactobiose

Galβ1,6Gal

–

18

1,4 GB

Galabiose

Galα1,4Gal

–

19

LB2TS

Linear B2 trisaccharide

Galα1,3Galβ1,4GlcNAc

–

20

β-Gal-OMe

β-Galactose-O-methyl

β-Gal-OMe

–

22

2’-FL

2’-Fucosyllactose

Fucα1,2Galβ1,4Glc

*The relative efficiencies of the acceptors as TbFUT1 substrates (+++, ++, +, and –) are based on visual inspection
of the intensities of the products bands in Figure 2.

Bandini, Damerow, et al. eLife 2021;0:e70272. DOI: https://doi.org/10.7554/eLife.70272



5 of 27

βG

LN
T
LN
nT
iL
N
O
LN
H
G
N
G
3’
-F
L
1,
6G
B
1,
4G
B
LB
2T
S

al
LN
nH

βG

cN
A
-c c
trl

La

LN
B

LN
B
La
cN
A
-c c
trl
La
c

c
La

al
-O
M
LN
e
BO
2’
-F Me
L

Biochemistry and Chemical Biology | Microbiology and Infectious Disease

Research article

products

Fuc

1

2

3

4

GST-TbFUT1

5

6

7

8

9

10

11

12

13

14

15

pGEX6P1 (mock)

16

17

18

19

20

21 22

GST-TbFUT1

Figure 2. Recombinant GST-TbFUT1 transfers [3 H]Fuc to a variety of sugar acceptors. Each assay used 2 μg of purified GST-TbFUT1, GDP-[3H]Fuc, and
1 mM of acceptor. Reaction products were desalted and separated by silica High Performance Thin Layer Chromatography (HPTLC) and detected by
fluorography. LNB, LNB-OMe, and LNB-terminating structures were the best acceptors tested. The acceptor abbreviations above each lane are defined
in Table 1. -ctrl: negative control reaction without acceptor (lane 4) or with buffer alone (lane 8).
The online version of this article includes the following figure supplement(s) for figure 2:
Figure supplement 1. Purification of recombinant GST-TbFUT1.
Figure supplement 2. TbFUT1 activity is independent of divalent metal cations.

when GDP-[3H]Fuc was incubated with reaction buffer alone (Figure 2, lane 8) or in the presence of
the material purified from the E. coli cells transformed with the empty vector (Figure 2, lanes 5–7).
These data suggest that TbFUT1 has a significant propensity to transfer Fuc to water. Interestingly,
one of the substrates (LNB-O-Me; Galβ1,3GlcNAcβ1-O-methyl) suppressed the amount of free Fuc
produced in the reaction (Figure 2, lane 21), suggesting that this glycan may bind more tightly to the
TbFUT1 acceptor site than the other oligosaccharides tested and thus prevent the transfer of Fuc from
GDP-Fuc to water. In vitro high sugar nucleotide hydrolysis activity has been previously described for
at least one member of the GT11 family (Zhang et al., 2010).
Inverting α-1,2 and α-1,6-FUTs do not usually require divalent cations for their activity (Beyer and
Hill, 1980; Kamińska et al., 2003; Li et al., 2008; Pettit et al., 2010). To study the divalent cation
dependence of TbFUT1, the assay was repeated in buffer without divalent cations or containing EDTA.
No change in activity was observed in either case, indicating TbFUT1 does not require divalent cations
for its activity (Figure 2—figure supplement 2).
Finally, given the propensity for TbFUT1 to transfer [3H]Fuc from GDP-[3H]Fuc to water, producing
free [3H]Fuc and presumably GDP, we set up a GDP-Glo assay similar to that used for LmjFUT1 (Guo
et al., 2021) to monitor the turnover by recombinant TbFUT1 of non-radioactive GDP-Fuc to GDP
(see Materials and methods). In this assay, we could see TbFUT1-dependent turnover of GDP-Fuc to
GDP in the absence of acceptor substrate (70 ± 2 pmol) and the stimulation of turnover in the presence of LNB acceptor substrate (265 ± 13 pmol), consistent with the results in the radiometric assay.
Under the same conditions, there was no detectible turnover of either GDP-Man or GDP-Glc, showing
that TbFUT1 is specific, or at least highly selective, for GPD-Fuc as donor substrate.

Characterization of the TbFUT1 reaction product
The glycan reaction products were structurally characterized to determine the anomeric and stereochemical specificity of TbFUT1. Initially, we performed exoglycosidase and/or acid treatment of
the radiolabelled reaction products (recovered by preparative TLC) utilizing Lac, LacNAc, and
LNB as substrates. The tritium label ran with the same mobility as authentic Fuc after acid hydrolysis of all three products (Figure 3—figure supplement 1A,C) and after Xanthomonas manihotis

Bandini, Damerow, et al. eLife 2021;0:e70272. DOI: https://doi.org/10.7554/eLife.70272
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α-1,2-
fucosidase digestion of the Lac and LNB
products (Figure 3—figure supplement 1B,C).
These data suggest that [3H]Fuc was transferred
in α1,2 linkage to the acceptor disaccharides.
To obtain direct evidence, we performed a
large-
scale activity assay using LNB-
O-
Me as
an acceptor and purified the reaction product
by normal phase HPLC. Fractions containing
the putative fucosylated trisaccharide product
(Figure 3—figure supplement 2) were pooled
and analysed for their neutral monosaccharide
content, which showed the presence of Fuc, Gal,
and GlcNAc. The purified reaction products were
permethylated and analysed by electrospray ionisation mass spectrometry (ESI-MS) (Figure 3A),
which confirmed that the main product was a
trisaccharide of composition dHex1Hex1HexNAc1.
The MS/MS spectrum was also consistent with the
dHex residue being attached to the Hex, rather
than HexNAc, residue (Figure 3B). Subsequently,
partially methylated alditol acetates (PMAAs)
were generated from the purified trisaccharide
product and analysed by gas chromatography
Figure 3. ESI-MS and ESI-MS/MS of TbFUT1 in vitro
coupled to mass spectrometry (GC-
MS). This
reaction product. (A) ESI-MS of the purified and
analysis identified derivatives consistent with
permethylated reaction product. The ion at m/z 692.5
the presence of non-
reducing terminal-
Fuc,
is consistent with the [M + Na]+ ion of a permethylated
trisaccharide of composition dHex1Hex1HexNAc1. Some 2-O-substituted Gal, and 3-O-substituted GlcNAc
of the unmodified acceptor (Hex1HexNAc1) was also
(Figure 4—figure supplement 1 and Table 2),
observed (m/z 518.4). (B) MS/MS product ion spectrum
consistent with Fuc being linked to position 2 of
of m/z 692.5. The collision-induced fragmentation
Gal. The GC-MS methylation linkage analysis also
pattern indicated that the dHex (Fuc) residue was
revealed a trace of 2-
O-
substituted Fuc in the
linked to the Hex (Gal) and not to the HexNAc (GlcNAc)
sample, which, together with the observation that
residue.
3′-FL, can act as a weak substrate (Figure 2, lane
The online version of this article includes the following
18, and Table 1), may suggest that TbFUT1 can
figure supplement(s) for figure 3:
also form Fucα1,2Fuc linkages.
Figure supplement 1. Preliminary characterization of
The purified TbFUT1 reaction product was
TbFUT1 reaction products.
also exchanged into deuterated water (2H2O)
Figure supplement 2. Purification of the TbFUT1
and analysed by one-
dimensional 1H-NMR and
1
reaction product by normal phase HPLC.
two-dimensional H-
ROESY (Rotating frame
Overhouser Effect SpectroscopY). The 1H-NMR
spectrum showed a doublet at about 5.1 ppm,
consistent with the signal from the proton on the anomeric carbon (H1) of an α-Fuc residue (Figure 4A).
Table 2. Partially methylated alditol acetates (PMAAs) derivatives identified by GC-MS methylation
linkage analysis of the purified TbFUT1 reaction product.
PMAA derivative

RT (min)

Origin

4,6-di-O-methyl-1,3,5-tri-O-acetyl-(1–2 H)- 2-N-
methylacetamidoglucosaminitol

24.6

3-O-substituted GlcNAc

2,3,4,6-tetra-O-methyl-1,5-di-O-acetyl-(1–2 H)-galactitol

16.7

Non-reducing terminal Gal

3,4,6-tri-O-methyl-1,2,5-tri-O-acetyl-(1–2 H)-galactitol

18.6

2-O-substituted Gal

2,3,4-tri-O-methyl-1,5-di-O-acetyl-(1–2 H)-fucitol

14.1

Non-reducing terminal Fuc

3,4-di-O-methyl-1,2,5-tri-O-acetyl-(1–2 H)-fucitol

15.9

2-O-substituted Fuc

RT: retention time.
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A characteristic doublet for the anomeric
proton of a β-Gal residue was also observed
at 4.5 ppm. In the 1H-ROESY spectrum, a cross-
peak (labelled a) could be observed indicating
a through-
space connectivity between the H1
of α-Fuc and the H2 of a β-Gal, consistent with
a Fucα1,2Gal linkage in the TbFUT1 reaction
product (Figure 4B). The chemical shifts that could
be clearly assigned by either one-dimensional 1H-
NMR or two-dimensional 1H-ROESY are listed in
Table 3.
Taken together, these data unambiguously define the structure of the TbFUT1 reaction product with GDP-
Fuc and LNB-
O-
Me as
Fucα1,2Galβ1,3GlcNAcβ1-O-CH3 which, in
turn, defines TbFUT1 as having a GDP-
Fuc:
β-Gal α-1,2-
fucosyltransferase activity with an
apparent preference for a Galβ1,3GlcNAcβ1-
O-R acceptor motif.

A

α-Fuc H1 doublet

ppm

8

7

6

5

4

3

2

1

0

B

3.2
3.4
3.6
3.8
4.0
4.2
4.4
4.6

Generation of TbFUT1 conditional
null mutants in procyclic and
bloodstream form T. brucei

4.8

a
5.2 5.0 4.8 4.6 4.4 4.2 4.0 3.8 3.6 3.4 3.2

5.0
5.2

ppm

Semi-
quantitative RT-
PCR showed that TbFUT1
mRNA was present in both bloodstream form
and procyclic form T. brucei (data not shown).
We therefore sought to explore TbFUT1 function in both lifecycle stages by creating TbFUT1
conditional null mutants. The strategies used to
generate the mutants are described in Figure 5.
The creation of these mutants was possible
The online version of this article includes the following
because genome assembly indicated TbFUT1 to
figure supplement(s) for figure 4:
be present as a single copy per haploid genome,
Figure supplement 1. GC-MS methylation linkage
and Southern blot analysis using a TbFUT1 probe
analysis of the purified reaction product.
was consistent with this prediction (Figure 5—
figure supplement 1). In procyclic cells (Figure 5,
left panel), the first TbFUT1 allele was replaced by
homologous recombination with linear DNA containing the puromycin resistance gene (PAC) flanked
by about 500 bp of the TbFUT1 5′- and 3′-UTRs. After selection with puromycin, an ectopic copy
of TbFUT1, under the control of a tetracycline-inducible promoter, was introduced in the ribosomal
DNA (rDNA) locus using phleomycin selection. Following induction with tetracycline, the second
allele was replaced with the BSD gene by homologous recombination, generating the final procyclic
form ΔTbFUT1::PAC/TbFUT1Ti/ΔTbFUT1::BSD conditional null mutant cell line (PCF TbFUT1 cKO). In
bloodstream form cells (Figure 5, middle panel), an ectopic copy of TbFUT1 carrying a C-terminal
MYC3 epitope tag under the control of a tetracycline-inducible promoter was first introduced into
Figure 4. 1H-NMR and 1 H-ROESY spectra of the
TbFUT1 reaction product. (A) One-dimensional
1
H-NMR spectrum. The arrow points to the α-Fuc H1
doublet. (B) Enlargement of the 3.2–5.1 ppm region
of the two-dimensional 1H-ROESY spectrum. (a)
indicates the crosspeak resulting from a through-space
connectivity between α-Fuc H1 and β-Gal H2.

Table 3. H-NMR and 1H-ROESY chemical shift assignments for the purified TbFUT1 reaction
product.
Residue

H1

H2

H3

H4

H5

H6/6'

αFuc

5.05 (J = 4 Hz)

3.57

3.67

3.63

4.2

1.1

βGal

4.5

3.45

3.55

3.89

ND

ND

βGlcNAc

ND

3.63

ND

3.4

ND

3.78/3.89

NAc

2.1

J: coupling constant. ND: chemical shift could not be clearly assigned.
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Figure 5. Cloning strategies for the creation of the TbFUT1 conditional null mutants. Left panel: To create the procyclic form conditional null mutant
(PCF TbFUT1 cKO), the first TbFUT1 allele was replaced by PAC, an ectopic tetracycline-inducible copy of the TbFUT1 gene was introduced into the
ribosomal DNA locus, and the second TbFUT1 allele was replaced by BSD. Middle panel: To create the bloodstream form conditional null mutant (BSF
TbFUT1-MYC3 cKO), an ectopic tetracycline-inducible copy of the TbFUT1 gene with a MYC3 tag was first introduced into the ribosomal DNA locus.
Both TbFUT1 alleles were subsequently replaced by HYG through homologous recombination followed by gene conversion. Right panel: To create the
untagged bloodstream form cKO (BSF TbFUT1 cKO), the BSF TbFUT1-MYC3 cKO mutant (middle panel) was modified by homologous recombination
with a construct that removed the C-terminal MYC3 tag under PAC selection. IGR: intergenic region.
The online version of this article includes the following figure supplement(s) for figure 5:
Figure supplement 1. Southern blots of TbFUT1 conditional null mutants.

the ribosomal DNA (rDNA) locus using phleomycin selection. Following cloning and induction with
tetracycline, the first TbFUT1 allele was then targeted for homologous recombination with linear DNA
containing the hygromycin resistance gene (HYG) flanked by about 1200 bp of the TbFUT1 5′- and
3′-UTRs. After selection with hygromycin, Southern blotting revealed that gene conversion had taken
place and that both TbFUT1 alleles had been replaced by HYG yielding a bloodstream form TbFUT1-
MYC3Ti/ΔTbFUT1::HYG/ΔTbFUT1::HYG conditional null mutant cell line (BSF TbFUT1-MYC3 cKO).
Southern blotting data confirming the genotypes of these mutants are shown in Figure 5—figure
supplement 1. The BSF cell line was also used to generate a TbFUT1Ti/ΔTbFUT1::HYG/ΔTbFUT1::HYG
conditional null mutant cell line by in situ homologous recombination of the tetracycline inducible
TbFUT1-MYC3 copy, converting it to an untagged TbFUT1 gene and generating BSF TbFUT1 cKO
(Figure 5, right panel).

TbFUT1 is essential to procyclic and bloodstream form T. brucei
Procyclic and bloodstream form TbFUT1 conditional null mutants were grown under permissive (plus
tetracycline) or non-permissive (minus tetracycline) conditions. The PCF TbFUT1 cKO cells grown
under non-permissive conditions showed a clear reduction in the rate of cell growth after 6 days,
eventually dying after 15 days (Figure 6A).
The BSF TbFUT1 cKO cells grew like wild-type cells under permissive conditions, whether or not
the expressed TbFUT1 had a C-terminal MYC3 tag, and under non-permissive conditions also showed
a clear reduction in the rate of cell growth after 2–4 days, dying after 3–5 days (Figure 6B,C). These
growth phenotypes are very similar to those described for procyclic and bloodstream form TbGMD
conditional null mutants that cannot synthesize GDP-Fuc under non-permissive conditions (Figure 6—
figure supplement 1; Turnock et al., 2007). This is consistent with the hypothesis that TbFUT1 may
be the only enzyme that utilizes GDP-Fuc, or at least that it is the only FUT transferring fucose to
essential acceptors. Further evidence that TbFUT1 is essential for procyclic and bloodstream form
growth was obtained from northern blots (Figure 6D,E). These show that TbFUT1 mRNA levels are
undetectable for several days after the removal of tetracycline, but that growth resumes only when
some cells escape tetracycline control after about 29 days (procyclic form) and 11 days (bloodstream
form). Escape from tetracycline control after several days is typical of conditional null mutants for
essential trypanosome genes (Roper et al., 2002). Evidence for the expression of the MYC3 tagged
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Figure 6. TbFUT1 is essential for procyclic and bloodstream form cell growth in vitro. The cell numbers (± standard deviation) for TbFUT1 cKO
under permissive (plus tetracycline, dotted line) and non-permissive (minus tetracycline, solid line) conditions are shown for three procyclic (A) and
bloodstream form (C) clones, as well as for three bloodstream clones carrying a tetracycline-inducible ectopic TbFUT1 gene with a C-terminal MYC3 tag
(B). For each clone procyclic form clone, two biological repeats were analysed and three for bloodstream form clones. (D, E) Corresponding TbFUT1
mRNA levels were determined by northern blots. Alpha-tubulin (TUB) was used as a loading control. (F) TbFUT1-MYC3 and untagged TbFUT1 are
detected by western blot analysis in the respective bloodstream form cKO cell lines under permissive conditions (+Tet). The left panel shows an anti-
MYC (αMYC) blot and the right panel an anti-recombinant TbFUT1 antibody (αFUT1) blot. Membranes were stained with Ponceau S (PS) to ensure equal
loading.
The online version of this article includes the following figure supplement(s) for figure 6:
Figure supplement 1. Comparison of TbFUT1 and TbGMD conditional null mutant growth.
Figure supplement 2. TbFUT1 and TbGMD cKO have increased cell size.
Figure supplement 3. The paraflagellar rod (PFR) and flagellar attachment zone (FAZ) appear normal in PCF TbFUT1 cKO.
Figure supplement 4. TbFUT1 and TbGMD cKO procyclic form cells show no defect in motility.

TbFUT1 protein in the BSF TbFUT1-MYC3 cKO cell line and of unmodified TbFUT1 in the BSF TbFUT1
cKO cell line under permissive conditions is shown in Figure 6F.
From a morphological point of view, both procyclic form TbGMD and TbFUT1 conditional null
mutants grown under non-permissive conditions showed an increase in average cell volume, due
to increased cell length, concomitant with the start of the cell growth phenotype (Figure 6—figure
supplement 2A). However, we were unable to reproduce the flagellar detachment phenotype previously reported for the PCF TbGMD cKO grown in non-permissive conditions (Turnock et al., 2007),
nor was such a phenotype observed in the PCF TbFUT1 cKO parasites, either by scanning electron
microscopy or immunofluorescence (IFA) (Figure 6—figure supplement 2C and Figure 6—figure
supplement 3). The percentage of cells displaying flagellar detachment (1.5–2%) in both null mutants
grown in non-permissive conditions (Figure 6—figure supplement 2B) was consistent with what has
previously been reported for wild-type cells (LaCount et al., 2002). Additionally, we could observe no
defect in cell motility in either PCF TbGMD or PCF TbFUT1 cKO grown in non-permissive conditions
(Figure 6—figure supplement 4).

TbFUT1 localizes to the parasite mitochondrion
The BSF TbFUT1-MYC3 cKO cell line, grown under permissive conditions, was stained with anti-MYC
antibodies and produced a pattern suggestive of mitochondrial localization. This was confirmed by
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co-localization with MitoTracker (Figure 7A). However, when TbFUT1 was introduced into wild-type
cells fused with an HA3 epitope tag at the N-terminus, either with or without a C-terminal MYC3-tag
(constructs pLEW100:HA3-FUT1-MYC3 and pLEW100:HA3-FUT1), the tagged protein co-localized with
GRASP, a marker of the Golgi apparatus (Figure 7B,C). In these cases, we suspect that N-terminal
tagging has disrupted mitochondrial targeting by obscuring the N-terminal mitochondrial targeting
sequence. Indeed, no mitochondrial targeting motif was predicted in silico for N-terminal HA3 tagged
TbFUT1. Nevertheless, since the mitochondrial localization of a FUT is unprecedented, we elected to
raise polyclonal antibodies against recombinant TbFUT1 to further assess its subcellular location. To
do so, an N-terminally His6-tagged Δ32TbFUT1 protein was expressed, re-solubilized from inclusion
bodies and used for rabbit immunization. The IgG fraction was isolated on immobilized protein-A
and the anti-
TbFUT1 IgG sub-
fraction affinity purified on immobilized recombinant GST-
TbFUT1
fusion protein. To further ensure mono-specificity of the antibodies to TbFUT1, the resulting fraction
was adsorbed against a concentrated cell lysate of the PCF TbFUT1 cKO mutant grown for 9 days
under non-permissive conditions. The resulting highly specific polyclonal antibody was used to detect
TbFUT1 expression in wild-type bloodstream form cells as well as in BSF and PCF TbFUT1 cKO cells
under permissive and non-permissive conditions (Figure 8A–C).
Anti-TbFUT1 antibodies co-localized with MitoTracker staining in the wild-type cells and in the
conditional null mutants under permissive conditions. No signal for the anti-TbFUT1 antibodies was
seen under non-permissive conditions, confirming the specificity of the polyclonal antibody. Taking
the possibility of a dual Golgi/mitochondrial localization into account, TbFUT1 localization was also
assessed in bloodstream form cells ectopically expressing TbGnTI-HA3 as an authentic Golgi marker
(Damerow et al., 2014). No co-localization between TbGnTI-HA3 and anti-TbFUT1 was observed,
suggesting that TbFUT1 is either exclusively or predominantly expressed in the parasite mitochondrion (Figure 8D).

Deletion of TbFUT1 disturbs mitochondrial activity
Bloodstream form wild-type and BSF TbFUT1 cKO cells, grown with and without tetracycline for
5 days, were stained with antibodies to mitochondrial ATPase and with MitoTracker. As expected,
ATPase and MitoTracker co-localized in wild-type cells and in the mutant under permissive conditions (Figure 9, top panels). However, under non-permissive conditions the few remaining viable cells
showed significantly diminished MitoTracker staining, indicative of reduced mitochondrial membrane
potential, and a reduction in ATPase staining, suggesting that TbFUT1 is in some way required for
mitochondrial function (Figure 9, lower panels, and Figure 9—figure supplement 1).

TbFUT1 can replace the homologous essential mitochondrial
fucosyltransferase in L. major
The essentiality and mitochondrial location of the orthologous protein in L. major, LmjFUT1, was
reported in Guo et al., 2021. Here we asked whether TbFUT1 could functionally substitute for
LmjFUT1 using a plasmid shuffle approach (Guo et al., 2017; Murta et al., 2009). We started with an
L. major homozygous fut1- null mutant expressing LmjFUT1 from the episomal pXNGPHLEO vector
which additionally expresses GFP (Guo et al., 2017; Murta et al., 2009) and transfected it with an
episomal construct pIR1NEO-TbFUT1 (±HA) expressing WT or HA-tagged TbFUT1. Following transfection, parasites were grown briefly in the absence of any selective drug, and single cells were sorted
for GFP expression and selected for phleomycin resistance, or GFP loss accompanied by G418 (NEO)
resistance (Figure 10A). In these studies, 85% (82/96) of the GFP-positive (GFP+) clonal lines (positive
control) grew when placed in microtiter wells, while 81% (156/192) of the GFP-negative (GFP-) sorted
cells likewise grew (Figure 10A). Control PCR studies confirmed the loss of TbFUT1 in the GFP- clones
(not shown). The similar survival of cells bearing Lmj or TbFUT1 provides strong evidence that the
TbFUT1 can fully satisfy the L. major FUT1 requirement (Murta et al., 2009).
Immunofluorescence microscopy of progeny Lmj fut1-/pIR1NEO-TbFUT1 (±HA)-transfected parasites with either mouse monoclonal anti-HA antibodies or affinity-purified rabbit polyclonal anti-
TbFUT1 antibodies showed that TbFUT1 was faithfully localized in the Leishmania mitochondrion
(Figure 10B). The Pearson r correlation for co-localization of the anti-HA or anti-TbFUT1 signals with
MitoTracker red was >0.98 in both experiments. In a negative control where anti-TbFUT1 antibody
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Figure 7. C- and N-terminal tagging of TbFUT1 result in mitochondrial and Golgi apparatus localization,
respectively. (A) Bloodstream form (BSF) cKO parasites expressing tet-inducible C-terminally tagged TbFUT1-MYC3
were imaged under permissive (+Tet) and non-permissive (-Tet) conditions by differential interference contrast
(DIC) and fluorescence microscopy after staining with anti-MYC, MitoTracker, and DAPI. Comparable patterns were
Figure 7 continued on next page
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Figure 7 continued

observed for anti-MYC and MitoTracker, suggesting that TbFUT1-MYC3 localizes to the mitochondrion. (B, C) IFA
of BSF cKO parasites expressing a tet-inducible N-terminally tagged HA3-TbFUT1-MYC3 (B) or HA3-TbFUT1 (C)
after labelling with anti-HA, anti-GRASP, and DAPI suggests a Golgi apparatus location for both HA3-TbFUT1-MYC3
and HA3-TbFUT1. The absence of anti-MYC (A) or anti-HA (B, C) staining under non-permissive conditions confirms
the specificity of the labelling for the respective TbFUT1 fusion proteins. White boxes: areas magnified 1.5× in the
rows below. Scale bars: 3 μm.

was omitted, the fluorescence signal was lost (data not shown). This result establishes conservation of
mitochondrial targeting of TbFUT1 when heterologously expressed in L. major promastigotes.

Discussion
The presence and essentiality of the nucleotide sugar donor GDP-Fuc in BSF and PCF trypanosomes
led us to search for putative FUTs in the parasite genome. Only one gene (TbFUT1; Tb927.9.3600),
belonging to the CAZy GT11 family, was found, and phylogenetic analyses revealed that one, or two
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Figure 8. Antibodies to the recombinant protein localize TbFUT1 to the mitochondrion. (A) IFA of wild-type bloodstream form (BSF) trypanosomes after
staining with affinity-purified anti-TbFUT1 (αFUT1) MitoTracker and DAPI. Comparable patterns were observed for αFUT1 and MitoTracker, suggesting
that TbFUT1 localizes to the mitochondrion. (B, C) TbFUT1 conditional null mutants were grown under permissive (+Tet) and non-permissive (-Tet)
conditions for 3 days in the case of BSF (B) or 7 days for PCF (C) and imaged.. In both cases, the tetracycline-inducible TbFUT1 pattern is consistent
with a mitochondrial localization. (D) BSF trypanosomes induced to express a C-terminally tagged known Golgi glycosyltransferase (TbGnTI-HA3) were
imaged after staining with αFUT1, anti-HA, and DAPI, as indicated. The merged images of two representative cells suggest no significant co-localization
between native TbFUT1 and the Golgi-localized TbGnT1. White boxes: areas magnified 1.5× in the rows below. Scale bars: 3 μm.
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Figure 9. Absence of TbFUT1 disturbs mitochondrial activity. Bloodstream form (BSF) wild-type and TbFUT1 cKO parasites were cultured for 5 days
under permissive (+Tet) and non-permissive (-Tet) conditions, fixed and labelled with MitoTracker for mitochondrial potential and with anti-mitochondrial
ATPase antibody. In mutants grown in non-permissive conditions (lower panels), both ATPase and MitoTracker staining are strongly reduced, suggesting
reduced mitochondrial functionality. Scale bar: 3 μm.
The online version of this article includes the following figure supplement(s) for figure 9:
Figure supplement 1. Absence of TbFUT1 disturbs mitochondrial activity.

in the case of T. cruzi, orthologue could be found in the genomes of other kinetoplastids. These putative kinetoplastid FUTs form a distinct clade within the GT11 FUT superfamily and are distinct from
the GT10 FUTs found in T. cruzi, L. major, and related parasites, which are absent in T. brucei. Consistent with TbFUT1 being the only enzyme likely to utilize the essential metabolite GDP-Fuc, we found
that TbFUT1 is also essential to both BSF and PCF parasites. We were able to express TbFUT1 in E.
coli, and the recombinant enzyme was used to demonstrate its activity as a GDP-Fuc: β-Gal α-1,2-
fucosyltransferase with an apparent preference for a Galβ1,3GlcNAcβ1-O-R acceptor motif out of
the acceptor substrates investigated.
Immunofluorescence analysis, using an affinity-purified antibody raised against native TbFUT1 as
well as C-terminal epitope tagging, suggests that TbFUT1 is located in the parasite mitochondrion.
Consistent with this, TbFUT1 was identified in the mitochondrial proteome of PCF T. brucei (Panigrahi et al., 2009). Although this was based on a single unique peptide, and is therefore not a
high-confidence assignment, this is the only proteomic dataset deposited on TriTrypDB (Aslett et al.,
2010) that identified TbFUT1. A quantitative proteomic analysis that estimated protein turnover in
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Figure 10. TbFUT1 can functionally and spatially replace LmjFUT1. (A) Outline of the ‘plasmid shuffling’ procedure to replace LmjFUT1 with TbFUT1.
An L. major homozygous fut1- null mutant expressing LmjFUT1 (from the GFP-positive, episomal pXNGPHLEO vector) was transfected with pIR1NEOTbFUT1 (±HA) expressing either WT or HA-tagged TbFUT1 (GFP-negative). Following transfection and growth in the absence of selective drugs, single
cells were sorted for GFP expression or loss. A similar yield of colonies was obtained from both populations. (B) TbFUT1 HA-tagged (top row) or WT
(bottom row) was expressed in an L. major chromosomal fut1- mutant background and analysed by indirect immunofluorescence using anti-HA or anti-
TbFUT1 antibodies. MitoTracker red was used as a mitochondrial marker. Scale bar: 2 μm.

T. brucei (Tinti et al., 2019), and ranking of protein abundances using those deep proteomic data
sets (Ji et al., 2021), did not identify TbFUT1 in either BSF or PCF, suggesting that it is a very low-
abundance protein. The immunofluorescence analysis performed in this study does not allow us to
define the specific localization of TbFUT1 in the parasite mitochondrion. Generally, proteins that are
targeted to the mitochondrion via an N-terminal presequence are translocated across both the outerand inner-mitochondrial membranes into the mitochondrial matrix where the presequence is proteolytically cleaved (Long et al., 2008). Since TbFUT1 has a predicted mitochondrial targeting sequence
(Figure 1A), we speculate that TbFUT1 may be located in the mitochondrial matrix. However, we are
mindful that the putative presequence also overlaps with the predicted FUT motif IV (Li et al., 2008).
Future work will address whether the FUT is indeed imported to the mitochondrial matrix, the inter-
membrane space, or the organelle outer membrane and will include the functional characterization
of the role of the predicted TbFUT1 mitochondrial targeting sequence in protein localization. These
studies will also assess the fate of motif IV and its function in TbFUT1 enzymology.
Regardless of the precise sub-organellar localization, the localization of TbFUT1 to the mitochondrion is a highly unusual result. Although in recent years fucosylation has been described in the
nucleus and cytosol of protists and plants (Bandini et al., 2016; Rahman et al., 2016; Van Der Wel
et al., 2002; Zentella et al., 2017), we are unaware of any other examples of mitochondrial FUTs in
any organism. Mitochondrial glycosylation in general is poorly understood. The only other known
example of a mitochondrial-
localized glycosyltransferase is mitochondrial O-GlcNAc transferase
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(mOGT) (Bond and Hanover, 2015). Mitochondria of rat cardiomyocytes are also positive for OGA
and express a UDP-GlcNAc transporter on their outer membrane, indicating all of the molecular
components required for this cycling post-translational modification are present in the organelle
(Banerjee et al., 2015). Interestingly, disruption of mOGT in HeLa cell mitochondria also leads to
mitochondrial dysfunction. While there are no (m)OGT orthologues in kinetoplastids, these observations highlight some of the challenges inherent for a mitochondrial-localized glycosyltransferase.
Firstly, for a TbFUT1 that localizes to either the intermembrane space or the mitochondrial matrix to
be active, GDP-Fuc would need to be imported into the mitochondrion, which would require the presence of an uncharacterized mitochondrial GDP-sugar transporter. Secondly, TbFUT1 appears to be an
α-1,2-FUT that decorates glycans terminating in Galβ1,3GlcNAc, suggesting either that additional
uncharacterized glycosyltransferases and nucleotide sugar transporters may be present in the parasite
mitochondrion, or that a glycoconjugate substrate may be assembled in the cytoplasm or secretory
pathway and then somehow translocated to or imported into the mitochondrion to be modified by
TbFUT1. Experiments to resolve these options will be undertaken, as will further experiments to try to
find the protein, lipid, and/or other acceptor substrates of TbFUT1. The latter may then provide clues
as to why TbFUT1 is essential for mitochondrial function and parasite growth. Several attempts to
identify TbFUT1 substrates have failed so far, including fucose-specific lectin blotting and pull-downs,
[3H]fucose labelling of parasites transfected with GDP-Fuc salvage pathway enzymes, and LC-MS/MS
precursor ion and neutral-loss scanning methods. Although the significance is unclear, it is interesting
to note that procyclic TbFUT1 has been shown to be under circadian regulation (Rijo-Ferreira et al.,
2017).
In conclusion, TbFUT1 is an essential -1,2-FUT that localizes to either outer membrane or inner
compartments of the parasite mitochondrion and presents orthologues throughout the kinetoplastida. As described in Guo et al., 2021, both activity and mitochondrial localization of the L. major
homologue are required for parasite viability, whereas other putative L. major FUTs targeted to the
secretory pathway are dispensable. Although no data are available so far on the enzymes from T. cruzi
or other members of this group, these initial results suggest the intriguing possibility of an essential, conserved mitochondrial fucosylation pathway in kinetoplastids that might be exploitable as a
common drug target.

Materials and methods

Key resources table

Reagent type (species) or
resource
Designation

Source or reference

Identifiers

Additional
information

Gene (Trypanosoma
brucei)

TbFUT1

Genedb.org

Tb927.9.3600

Strain, strain background
(Trypanosoma brucei)

Strain 427, clone 29.13 (PCF
WT)
Wirtz et al., 1999

Procyclic form

Strain, strain background
(Trypanosoma brucei)

Strain 427, variant MITaT
1.2 (BSF WT)

Wirtz et al., 1999

Bloodstream form

Strain, strain background
(Leishmania major)

L. major Friedlin V1

Guo et al., 2017

Strain, strain background
(Escherichia coli)

BL21 (DE3)

Agilent

Strain, strain background
(Escherichia coli)

BL21 Gold(DE3)

Agilent

Recombinant DNA
reagent

pLEW100

Prof. George Cross (Rockefeller University)

Recombinant DNA
reagent

pMOTag4YH-PAC

Prof. Thomas Seebeck (University of Bern);
Oberholzer et al., 2006

(Plasmid)

Recombinant DNA
reagent

pIR1NEO

Guo et al., 2021

(Plasmid)

MHOM/IL/80/Friedlin

Addgene Plasmid #24011

(Plasmid)

Continued on next page
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Recombinant DNA
reagent

pGEX6P1-GST-PP

Prof. Daan Van Aalten (University of
Dundee)

(Plasmid)

Recombinant DNA
reagent

pET15b

Novagen

(Plasmid)

Chemical compound,
drug

GDP[3H]Fuc

American Radiochemicals

Chemical compound,
drug

Galβ1,3GlcNAcβ-OMe
(LNB-O-Me)

Toronto Research Chemicals

Peptide, recombinant
protein

X. manihotis α–1,2-
fucosidase

New England Biolabs

Commercial assay or kit

GDP-Glo Kit

Promega

Other

MitoTracker Red CMX Ros

Thermo Fisher

Antibody

(Rabbit polyclonal) anti-
TbFUT1 IgG

This study: antibody generated as
described in Materialsandmethods

(1:1000)

Antibody

(Rabbit polyclonal) anti-
GRASP IgG

Prof. Graham Warren (University College
London)/Prof. Chris de Graffenreid (Brown
University)

(1:1000)

Antibody

(Rabbit polyclonal) anti-
ATPase IgG

Prof. David Horn (University of Dundee)

(1:1000)

Antibody

(Mouse polyclonal) anti-
FAZ IgM

Prof. Keith Gull (University of Oxford)

(1:2)

Prof. Keith Gull (University of Oxford)

(1:10)

Antibody

(Mouse polyclonal) anti-
PFR IgG

Parasite strains
T. brucei procyclic form (strain 427, clone 29.13) and bloodstream form (strain 427, variant MITaT 1.2)
were used in these experiments. Both strains are stably expressing T7 polymerase and tetracycline
repressor protein under G418 (bloodstream) or G418 and hygromycin (procyclic) selection (Wirtz
et al., 1999). Procyclic form T. brucei was cultured in SDM-79 medium (Brun and Schönenberger,
1979) containing 15% fetal bovine serum and GlutaMAX at 28 °C. Bloodstream form T. brucei was
grown in HMI-9t at 37 °C, 5% CO2. Induction was performed at 0.5 μg/ml tetracycline in both forms.

BLASTp searches
The T. brucei, T. cruzi, and L. major predicted proteins (from the GeneDB database, http://www.
genedb.org) were searched for putative FUTs using the BLASTp search algorithm (Altschul et al.,
1997). The query input sequences are listed in Supplementary file 1. Protein sequence multiple alignments were assembled using Clustal (Sievers et al., 2011) and Jalview (Waterhouse et al., 2009).

Cloning, protein expression, and purification of TbFUT1
The open reading frame (ORF) was amplified by PCR from T. brucei strain 427 genomic DNA and
cloned into the N-
terminal GST fusion vector pGEX-
6P-1, modified to contain the PreScission
Protease site (kind gift of Prof. Daan Van Aalten) using primers P1 and P2 (Supplementary file 2).
Either the resulting pGEX6P1-
GST-
PP-
TbFUT1 or pGEX6P1-
GST-
PP were transformed into BL21
(DE3) E. coli strain. Recombinant protein expression was induced with 0.1 mM isopropyl-β-D-
thiogalactopyranoside (IPTG) and carried out at 16 °C for 16 hr. Prior to lysis by French press, cells
were incubated for 30 min on ice in 50 mM Tris-HCl, 0.15 M NaCl, 1 mM DTT, pH 7.3 (Buffer A) with
EDTA-free Complete Protease Inhibitors Tablet (Roche) and 1 mg/ml lysozyme. The soluble fraction,
obtained by centrifugation at 17,000 × g, 4 °C for 30 min, was incubated 2 hr at 4 °C with Glutathione
Sepharose Fast Flow beads that had been pre-equilibrated in Buffer A. The mixture was loaded into
a disposable column and the beads washed first with 50 mM Tris-HCl, 0.25 M NaCl, 1 mM DTT, pH
7.3 (Buffer B), then with 50 mM Tris-HCl, 0.15 M NaCl, 0.1% sodium deoxycholate, 1 mM DTT, pH
7.3 (Buffer C), before being re-equilibrated in Buffer B. GST-TbFUT1 or GST were eluted in 50 mM
Tris-HCl, 0.15 M NaCl, 10 mM reduced glutathione pH 8.0 (Buffer E). The yield of recombinant protein
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was estimated by Bradford assay and the degree of purification by SDS-PAGE analysis. Recombinant
protein identification by peptide mass fingerprinting was performed by the Proteomic and Mass Spectrometry facility, School of Life Sciences, University of Dundee.

Fucosyltransferase activity assays
Radioactive assay
Aliquots of 2 μg of affinity-purified GST-TbFUT1 were incubated with 1 μCi GDP[3H]Fuc (American
Radiochemicals), 1 mM acceptor in 50 mM Tris-HCl, 25 mM KCl, 5 mM MgCl2, 5 mM MnCl2, pH
7.2 for 2 hr at 37 °C. The acceptors tested (Table 1) were purchased from Sigma, Dextra Laboratories, or Toronto Research Chemicals. To study the dependency on divalent cations, MgCl2 and MnCl2
were removed from the buffer and a formulation with 10 mM EDTA was also tested. Reactions were
stopped by cooling on ice then desalted on mixed bed as follows: 100 μl each Chelex100 (Na+) over
Dowex AG50 (H+) over Dowex AG3 (OH-) over QAE-Sepharose A25 (OH-). The flow through and the
elutions (4 × 400 μl of water) were combined. About 5% of the desalted reactions were counted at a
LS 6500 scintillation counter (Beckmann). The remaining material was lyophilized for further analyses.

Luminescence assay
Recombinant GST-TbFUT1 fusion protein was expressed in E. coli as described above, except that
cell lysis was performed without lysozyme using a Cell Disruptor (Constant Systems) in place of a
French press. After lysis, the suspension was centrifuged at 45,000× g, 30 min, 4 °C, and the fusion
protein was purified using glutathione Sepharose 4B. SDS-PAGE analysis of the glutathione-eluted
purified GST-TbFUT1 was like that shown in (Figure 2—figure supplement 1). The purified GST-
TbFUT1 was diluted 1:10 into assay buffer and 20 μl aliquots containing about 0.1 μg of GST-TbFUT1
(and no-enzyme controls) were incubated with GDP-Fuc, GDP-Man, or GDP-Glc (final concentrations
50 mM Tris-HCl, pH 7.2, 25 mM KCl, 50 μM GDP-sugar), with and without 0.8 mM LNB, overnight at
room temperature in 96-well flat-bottom luminometer plates (Corning Costar 3688). Reactions were
stopped and developed with 25 μl Promega GDP-Glo reagent and after 1 hr luminescence was read
on a BMG Labtech Pherostar plate reader. A calibration curve using 25 μl aliquots of GDP from 0 to
25 μM in assay buffer was developed in parallel. All measurements were performed in triplicate.

HPTLC analysis
Reaction products and standards were dissolved in 20% 1-propanol and separated on a 10 cm HPTLC
Si-60 plates (Merck) using 1-propanol:acetone:water 9:6:4 (v:v:v) as mobile phase. Non-radiolabelled
sugars were visualized by orcinol/H2SO4 staining. In the case of radiolabelled products, the HPTLC
plates were sprayed with En3hance (PerkinElmer) and visualized by fluorography.

Recovery of radiolabelled products
The reaction products from the TbFUT1 activity assays using Lac, LNB, and LacNAc as acceptors were
separated on a 20 cm HPTLC Si-60 plate. The radiolabelled products were localized on the HPTLC
plate using an AR-2000 (BioScan) plate reader, the corresponding areas were wetted with mobile
phase, and the silica scraped and transferred to microcentrifuge tubes. The radiolabelled materials
were extracted from the solid phase by incubating with mobile phase and a 5% aliquot counted at
the scintillation counter to determine the amount of recovered material.

Acid hydrolysis
Aliquots corresponding to 15% of the extracted radiolabelled reaction products were dried in a
Speedvac concentrator, re-dissolved in 4 M TFA, and incubated at 100 °C for 4 hr (Ferguson, 1992).
After cooling, the samples were dried on a Speedvac concentrator, washed in water, and re-dissolved
in 20% 1-propanol to be analysed by HPTLC as described in the main text.

Xanthomonas manihotis α-1,2-fucosidase reaction
Aliquots corresponding to 15% of the extracted radiolabelled reaction products were treated or
mock treated with 10 U X. manihotis α-1,2-fucosidase (New England Biolabs) at 37 °C for 16 hr. The
reactions were stopped by heating at 100 °C for 10 min and desalted on mixed bed columns as
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described for the activity assay. After freeze-drying, samples were washed with water, re-dissolved in
20% 1-propanol, and analysed by HPTLC.

Large-scale TbFUT1 assay and product purification
Acceptor (5 mM lacto-N-biose-β-O-methyl) and donor (2.5 mM GDP-Fuc) were incubated with 8 μg
affinity-purified GST-TbFUT1 in 20 mM Tris-HCl, 25 mM KCl, pH 7.2 at 37 °C for 24 hr. The reaction products were desalted on a mixed-bed column and lyophilized (see above). The trisaccharide
product was then isolated by normal phase liquid chromatography. The reactions were dissolved
in 95% acetonitrile (ACN) and loaded on a Supelco SUPELCOSYL LC NH2 HPLC column (7.5 cm ×
3 mm, 3 μm) using an Agilent 1,120 Compact LC system. The purification was performed at 40 °C
with a 0.3 ml/min flow rate. The column was equilibrated in 100% Buffer A (95% ACN, 5% H2O) for
5 min, before applying a first gradient from 0% to 35% Buffer B (95% H2O, 5% ACN, 15 mM ammonium acetate) over 25 min followed by a second gradient from 35% to 80% Buffer B over 20 min. The
column was then re-equilibrated in 100% Buffer A for 10 min. About 1.5% of each fraction was potted
onto a silica HPTLC plate and stained with orcinol/H2SO4 staining to identify the sugar-containing
fractions. An aliquot from each orcinol-positive fraction was then analysed by HPTLC, and the ones
containing the putative trisaccharide product were pooled and freeze-dried.

Permethylation, ESI-MS analysis, and GC-MC methylation linkage analysis
Purified TbFUT1 reaction product was dried and permethylated by the sodium hydroxide method as
described in Ferguson, 1992. Aliquots were used for ESI-MS and the remainder was subjected to
acid hydrolysis followed by NaB2H4 reduction and acetylation (Ferguson, 1992). The resulting PMAAs
were analysed using an HP6890 GC System equipped with an HP-5 column linked to a 5975C mass
spectrometer (Agilent). For ESI-MS and ESI-MS/MS, the permethylated trisaccharide was dried and
re-dissolved in 80% ACN containing 0.5 mM sodium acetate and loaded into gold-plated nanotips (Waters) for direct infusion. The Q-Star XL mass spectrometer equipped with Analyst software
(Applied Biosystems) was operated in positive ion mode using an ion spray voltage of 900 V and a
collision voltage of 50–60 V in MS/MS mode.

NMR
The purified TbFUT1 reaction product was exchanged in 2H2O by freeze-drying and analysed by one-
dimensional 1H-NMR and two-dimensional 1H-ROESY. All spectra were acquired on a Bruker Avance
spectrometer operating at 500 MHz with a probe temperature of 293 K.

Generation and expression of epitope-tagged TbFUT1 constructs
TbFUT1 was introduced in two different sites of pLEW100HXM to yield HA3-
TbFUT1 and HA3-
TbFUT1-MYC3. Starting from the pLEW100 vector, we inserted a 99 bp adapter oligo encoding for the
following sequence HindIII/NdeI/AscI/BbvCI/XbaI/BstBI/XhoI/HA/PacI/BamHI, where HA stands for a
single HA tag (O1 and O2 in Supplementary file 2). The HA tag was then replaced with a MYC3 tag
amplified from a pMOTag43M plasmid, creating the following multiple cloning site: HindIII/NdeI/AscI/BbvCI/XbaI/BstBI/XhoI/MYC3/PacI/BamHI. This vector was given the name pLEW100XM. TbFUT1
was amplified from a plasmid source using primers P15/P16 and inserted via HindIII/XhoI. pLEW100XM
was then used to introduce an HA3 adapter which would allow N-terminal tagging of a protein of
choice. The adapter consisted of the O3/O4 primer pair (Supplementary file 2). The primer pair was
fused and inserted into HindIII/AscI restriction sites of pLEW100XM creating the following multiple
cloning site: HindIII/HA3/AscI/BbvCI/XbaI/BstBI/XhoI/MYC3/PacI/BamHI. This plasmid was termed
pLEW100HXM. TbFUT1 was amplified using primers P21/P22 for HA3-TbFUT1 and P23/P16 for HA3-
TbFUT1-MYC3 (Supplementary file 2). The two plasmids were purified and electroporated into BSF
cells as described below.

Generation of TbFUT1 conditional null mutants
About 500 bp of the 5′ and 3′ untranslated regions (UTRs) immediately flanking the TbFUT1 ORF were
amplified from T. brucei 427 genomic DNA (gDNA) using primers P3/P5 and P4/P6 (Supplementary
file 2) and linked together by PCR, and the final product was ligated into pGEM-5Zf(+). Antibiotic
resistance cassettes were cloned into the HindIII/BamHI restriction sites between the two UTRs to
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generate constructs either containing puromycin acetyltransferase (PAC) or blastacidin S deamidase
(BSD). To allow cloning of the antibiotic resistance cassettes using HindIII/BamHI, a BamHI site present
in the 5′-UTR was first mutated to ggctcc using the QuickChange Site-Directed Mutagenesis Kit (Stratagene) and primers P7/P8. These two constructs were used to replace the two gene copies in procyclic form parasites. In addition, a hygromycin (HYG)-based TbFUT1 gene replacement cassette was
generated with longer UTRs (1.25 kb) amplified using primers P9/P10 (5′ UTRs) and P11/P12 (3′UTRs).
To avoid the endogenous 5′ UTR site, first the 3′UTR was introduced via BamHI/SacI then the 5′UTR
via SpeI/HindIII. The HYG resistance cassette replaced both copies of TbFUT1 in bloodstream form
parasites. The tetracycline-inducible ectopic copy construct was generated by amplifying the TbFUT1
ORF from T. brucei gDNA (primers P13/P14) and cloning the resulting PCR product into pLEW100.
Additionally, pLEW100XM was generated which allowed universal tagging of a protein of interest
with a C-terminal MYC3 tag (see details below). Linearized DNA was used to transform the parasites
as previously described (Burkard et al., 2007; Güther et al., 2006; Wirtz et al., 1999). The genotype
of the transformed parasites was verified by Southern blot as detailed below. The TbFUT1-MYC3 cell
line was used as parental strain for the BSF TbFUT1 cKO cell line by eliminating the MYC3 tag and
inserting a cassette comprised of the native (untagged) TbFUT1 gene, a short intergenic region (IGR),
and the PAC resistance gene via homologous recombination. A C-terminal fragment of the TbFUT1
ORF (nucleotides 444 to end) was amplified with primers P28/29 (Supplementary file 2) and cloned
into the KpnI/ApaI restriction sites of pMOTag4YH-PAC (Oberholzer et al., 2006), a kind gift of Prof.
Thomas Seebeck (University of Bern). The eYFP-3xHA cassette encoded in the plasmid was removed
by XhoI/SalI digestion followed by re-ligation. Finally, the rDNA homology sequence was digested
with NotI/SacI from pLEW100HXM and cloned into these same sites downstream of the puromycin
resistance gene (PAC), resulting in pMOTag-TbFUT1-IGR-PAC-rDNA. The linearized plasmid was electroporated in BSF TbFUT1-MYC3 cKO. Homologous recombination via the TbFUT1 C-terminus and
rDNA sequences resulted in generation of BSF TbFUT1 cKO (Figure 5C).

Southern blotting
Genomic DNA was prepared from 5 × 107 or 1 × 108 cells using DNAzol (Helena Biosciences) and
digested with 0.1 mg/ml RNAse I. The gDNA (5 μg/lane) was digested with the appropriate restriction endonucleases and probed with the ORFs of TbFUT1, puromycin acetyltransferase gene (PAC),
hygromycin B phosphotransferase (HYG), or blastacidin S deamidase gene (BSD) generated using
the PCR DIG Probe Synthesis Kit (Roche). The blot was developed according to the manufacturer’s
instructions.

Northern blotting
Total RNA was prepared from 5 × 106 to 1 × 107 cells using the RNeasy MIDI Kit (Qiagen) according to
the manufacturer’s instructions. The RNA was separated on a 2% agarose-formaldehyde gel, blotted,
and detected using the Northern Starter Kit (Roche). Probes were designed based on the DIG RNA
Labelling Kit T7 (Roche), and TbFUT1 and alpha-tubulin (Tb427.01.2340) templates were amplified
from T. brucei bloodstream form gDNA using primers P17/P18 and P19/P20 (Supplementary file 2),
respectively. Total RNA and DIG labelled probes were quality checked by capillary electrophoresis on
an Agilent BioAnalyzer 2100.

Growth curves
Growth of parasites lacking TbFUT1 was analysed by determining cell counts for three clones each of
PCF TbFUT1 cKO and BSF TbFUT1 cKO with either tagged of untagged TbFUT1. All cell lines were
washed in media without tetracycline (tet) and inoculated at a concentration of 5 × 105 parasites/ml
(procyclic form) and 2 × 104 parasites/ml (bloodstream form). Parasites were grown plus and minus
tetracycline and in biological duplicates (PCF) or triplicates (BSF). Cells were counted every 24 hr using
a CASY Cell Counter + Analyser system. To keep parasites in log phase, cultures were diluted back to
the initial inoculum concentration every 48 hr.

Preparation of anti-FUT1 antibody
The NdeI site within the TbFUT1 sequence was eliminated using the QuickChange Lightning Site-
Directed Mutagenesis Kit (Agilent) and primers P24/P25. The resulting mutagenized ORF was then

Bandini, Damerow, et al. eLife 2021;0:e70272. DOI: https://doi.org/10.7554/eLife.70272



20 of 27

Research article

Biochemistry and Chemical Biology | Microbiology and Infectious Disease

amplified with primers P26/P27 and cloned into pET15b, resulting in an N-
terminally truncated
construct encoding Δ32TbFUT1 fused to an N-terminal hexahistidine tag (HIS6) with PreScission plus
(PP) protease cleavage site. E. coli BL21 gold (DE3) cells were allowed to express His6-PP-TbFUT1
overnight at 25 °C in auto-inducing media (5052-NPS-MgSO4). Cells were harvested by centrifugation
and incubated for on ice in 50 mM Tris-HCl pH 7.3, 0.15 M NaCl, 1 mM DTT (Buffer A) with EDTA-free
Complete Protease Inhibitors Tablet (Roche), before being disrupted in a French Press. Since all of the
protein was insoluble within inclusion bodies, a refolding procedure was applied. The cell lysate was
spun down for 20 min at 20,000 g and the pellet was washed in ice-cold PBS with EDTA-free Complete
Protease Inhibitors Tablet (Roche). Cell debris layering the inclusion body pellet was scratched off and
the pellet washed again. This process was repeated three times. The inclusion body pellet was washed
with PBS + 0.5% TX-100 and sonicated on ice. After digestion of residual DNA and RNA, the pellet
was washed with PBS + 0.1% Tween-20, sonicated, and washed in TBS. The washed inclusion bodies
were resuspended in 8 M urea/TBS and incubated overnight at 37 °C, 200 rpm. Insoluble material
was spun down and the supernatant slowly diluted down under agitation to 2 M urea with TBS at
room temperature. After centrifugation, the supernatant concentrated to 2 mg/ml in a 30 kDa cut-off
VivaSpin concentrator. Re-solubilized protein (2 mg) was sent to DC Biosciences Ltd for production of
polyclonal rabbit antiserum. The IgG fraction from the hyperimmunized rabbit serum was purified on 2
× 1 ml HiTrap Protein G HP columns (GE Healthcare) and then affinity-purified on GST-TbFUT1 fusion
protein coupled to a HiTrap NHS-Activated HP column (GE Healthcare). Finally, the IgG fraction was
adsorbed against PCF TbFUT1 cKO cell lysates prepared on day 9 without tetracycline, a time point
at which they are virtually free of TbFUT1. The cell lysate was prepared by sonication of 2 × 108 cells
on ice in 100 mM sodium phosphate buffer pH 7 including EDTA-free Complete Protease Inhibitors
(Roche) and 0.01% TX-100. After addition of purified TbFUT1-specific IgGs to the cell lysate, the
solution was incubated rotating overnight at 4 °C, concentrated in a VivaSpin 30 kD cut-off filter, and
stored in 50 % glycerol at –20 °C. Final estimated rabbit anti-TbFUT1 IgG concentration was 50 µg/ml.

Immunofluorescence microscopy
Late log phase T. brucei bloodstream form or procyclic cells were fixed in 4% PFA/PBS in solution
at a concentration of 5 × 106 cells/ml. When using MitoTracker Red CMX Ros, cell cultures were
spiked with a 25 nM concentration over 20 min before harvesting. Fixed parasites were permeabilized in 0.5% TX-100 in PBS for 20 min at room temperature before blocking in 5 % fish skin gelatine (FSG) containing 0.1% TX-100 and 10% normal goat serum. Alternatively, procyclic cells were
permeabilized in 0.1% TX-100 in PBS for 10 min and blocked in 5% FSG containing 0.05% TX-100
and 10% normal goat serum. Primary antibody incubations were performed in 1% FSG, 0.1% TX-100
in PBS. The following primary antibodies were used in 1:1000 dilutions: rabbit anti-TbFUT1 IgG (see
above), rabbit anti-GRASP IgG (gifts from Prof. Graham Warren, University College London, and Prof.
Chris de Graffenreid, Brown University), rabbit anti-ATPase IgG (gift from Prof. David Horn, University
of Dundee), mouse anti-HA IgM (Sigma), rabbit anti-HA IgG (Invitrogen), and mouse anti-MYC IgM
(Millipore). Anti-FAZ was used at 1:2 and anti-PFR at 1:10 (both antibodies were kind gifts of Prof.
Keith Gull, University of Oxford). After washing, the coverslips were incubated with a 1:500 dilution
of respective secondary Alexa Fluor goat IgG, like anti-mouse 488 and 594, as well as anti-rabbit 488
and 594 (Life Technologies). Coverslips were mounted on glass slides with Prolong Gold DAPI antifade
reagent (Invitrogen). Microscopy was performed on a DeltaVision Spectris microscope (GE Healthcare), and images were processed using Softworx. For Figure 6—figure supplement 3, microscopy
was performed on a Zeiss LSM 700 confocal microscope. All images were further processed using Fiji
(Schindelin et al., 2012).

Scanning electron microscopy
Samples were prepared and analysed as described in Turnock et al., 2007. Briefly, PCF TbFUT1 cKO
cells were grown in the presence or absence of tetracycline and fixed on days 6 and 12 in SDM-79
with 2.5% glutaraldehyde, and the samples were further prepared by the Dundee Imaging Facility,
School of Life Sciences. Cells were collected on 1 μM Shandon Nuclepore membrane filters, rinsed
twice in 0.1 M PIPES buffer pH 7.2, and treated with 0.2% osmium tetroxide overnight. Samples were
then washed in water and in a gradient of ethanol solutions to dehydrate them. After critical point
drying on a BALTec critical point dryer D30, the samples were mounted on aluminium stubs that were
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then coated with 40 nM gold/palladium. The stubs were examined in a Philips XL30 environmental
scanning electron microscope operating at an accelerating voltage of 15 kV.

Cell volume determination
The average cell volume was obtained by analysing PCF TbFUT1 cKO and TbGMD cKO on a CASY
Cell Counter + Analyser system. Procyclic form cultures grown in the presence or absence of tetracycline were diluted 1:10 in 1× PBS before being diluted in the CASY-ton solution for measurements
(>4000 cells/measurement). Two biological replicates were analysed for procyclic form grown in the
absence of tetracycline. The p values were calculated performing a two-sided t-test in RStudio.

Sedimentation assay
The assay was adapted from Bastin et al., 1999. Briefly, about 5 × 106 T. brucei PCF TbFUT1 cKO or
TbGMD cKO cells were resuspended in 1 ml of SDM-79 medium and transferred into a 2 ml polystyrene cuvette (Sarstedt). The cuvettes were incubated at 28 °C (CPS-controller, Shimadzu) in a UV-1601
Spectrophotometer (Shimadzu) and the optical density at 600 nm measured every 30 min. SDM-79
medium was used as a blank. Two biological replicates were analysed for each cell line grown in the
presence or absence of tetracycline.

L. major complementation by ‘plasmid shuffling’
For the plasmid swap experiments described in Figure 10, the TbFUT1 ORF was amplified by PCR and
inserted into the expression vector pIR1NEO yielding pIR1NEO-TbFUT1 (B7148). L. major parasites
were grown as promastigotes in M199 medium, transfected, and plated on selective media for clonal
lines as described previously (Guo et al., 2017). ‘Plasmid shuffling’ to swap an episomal LmjFUT1-
expressing construct with the ones expressing-TbFUT1 (±HA tag) was performed as described in the
text and Figure 10A, following procedures described in Guo et al., 2017.
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